← Open Payments lookup

CYNTHIA BEDELL: Open Payments

NPI 1306976436 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,104 in 38 payments from 14 companies in 2025. Trend: 2023 $32,771 · 2024 $16,047 · 2025 $2,104

Long term medical supply or device loan: $1,097Food & beverage: $607Consulting: $400
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation13$1,158
Daiichi Sankyo Inc.1$400
Incyte Corporation5$119
Stemline Therapeutics Inc.4$86
Lilly USA, LLC3$75
ABBVIE INC.3$75
PUMA BIOTECHNOLOGY, INC.2$33
AstraZeneca Pharmaceuticals LP1$31
Genentech USA, Inc.1$29
Bayer Healthcare Pharmaceuticals Inc.1$23

Products named: KISQALI, Enhertu, Orserdu, MONJUVI, VERZENIO, EPKINLY, JAKAFI, NERLYNX.

Industry payments across TX — which companies pay providers there.